Humacyte

Last updated: October 09, 2024

Laura E. Niklason, Founder
Laura E. Niklason, Founder
USA | Funding: $733.1M (+)

Website: http://www.humacyte.com/

Humacyte develops novel human tissue-based investigational products for potential applications in regenerative medicine and vascular surgery. The company uses a proprietary technology platform to isolate and grow stable, “off-the shelf” investigational human tissue replacements that, if approved, could be tailored to pre-designed clinical and commercial specifications.